Find the latest for BioDefense company news
Cybersecurity is undergoing a major transformation with the rise of artificial intelligence. Deepak Gandham, a thought leader in AI-driven security, explores the latest advancements in threat detection and response in his latest research.
Mycotoxins have long been a pervasive challenge in agriculture and food production, threatening both animal and human health. As naturally occurring
Anduril president Christian Bose said the AI-powered defence start-up, whose founder left Facebook over his early support of Donald Trump, has good "vibes" about the Trump administration's shakeup of defence and willingness to do things differently.
Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.
Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.
A new National Academies report recommends ways for the U.S. to reap the benefits of artificial intelligence in biotechnology while minimizing risks that AI may be misused to develop harmful biological agents.
The rise of DeepSeek has prompted the usual well-documented concerns around AI, but also raised worries about its potential links to the Chinese state. The Security Think Tank considers the steps security leaders can take to counter threats posed by nation state industrial espionage?
Security guardrails for artificial intelligence applications startup Pangea Cyber Corp. today announced the general availability of two new services that help secure AI by defending against threats such as prompt injection and sensitive information disclosure.